BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hayashi PH, Lucena MI, Fontana RJ, Bjornsson ES, Aithal GP, Barnhart H, Gonzalez-Jimenez A, Yang Q, Gu J, Andrade RJ, Hoofnagle JH. A revised electronic version of RUCAM for the diagnosis of DILI. Hepatology 2022. [PMID: 35014066 DOI: 10.1002/hep.32327] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Di Zeo-sánchez DE, Segovia-zafra A, Matilla-cabello G, Pinazo-bandera JM, Andrade RJ, Lucena MI, Villanueva-paz M. Modeling drug-induced liver injury: current status and future prospects. Expert Opinion on Drug Metabolism & Toxicology. [DOI: 10.1080/17425255.2022.2122810] [Reference Citation Analysis]
2 Lunghi C, Trevisan C, Fusaroli M, Giunchi V, Raschi E, Sangiorgi E, Domenicali M, Volpato S, De Ponti F, Poluzzi E. Strategies and Tools for Supporting the Appropriateness of Drug Use in Older People. Pharmaceuticals 2022;15:977. [DOI: 10.3390/ph15080977] [Reference Citation Analysis]
3 Woo SM, Alhaqqan DM, Gildea DT, Patel PA, Cundra LB, Lewis JH. Highlights of the drug-induced liver injury literature for 2021. Expert Rev Gastroenterol Hepatol 2022. [PMID: 35839342 DOI: 10.1080/17474124.2022.2101996] [Reference Citation Analysis]
4 Weber S, Gerbes AL. Challenges and Future of Drug-Induced Liver Injury Research-Laboratory Tests. Int J Mol Sci 2022;23:6049. [PMID: 35682731 DOI: 10.3390/ijms23116049] [Reference Citation Analysis]
5 Devarbhavi H, Kurien SS. Letter to the editor: A revised electronic version of RUCAM for the diagnosis of drug-induced liver injury. Hepatology 2022. [PMID: 35451140 DOI: 10.1002/hep.32522] [Reference Citation Analysis]
6 Danan G, Teschke R. Letter to the editor: Electronic RUCAM: Major pitfalls call for caution and proper validation. Hepatology 2022. [PMID: 35243675 DOI: 10.1002/hep.32440] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]